# FDA Inspection 732413 - Summit Medical, Inc. - June 07, 2011

Source: https://www.keypedia.com/records/fda_inspections/summit-medical-inc/eb89baa9-e1bc-4e7b-b34b-9e5cd1418599
Source feed: FDA_Inspections

> FDA Inspection 732413 for Summit Medical, Inc. on June 07, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 732413
- Company Name: Summit Medical, Inc.
- Inspection Date: 2011-06-07
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 829873 - 2013-05-02](https://www.keypedia.com/records/fda_inspections/summit-medical-inc/7fc71162-0ee4-4525-82c3-ed545a94b634)

Company: https://www.keypedia.com/companies/summit-medical-inc/94988c12-6b13-4d9e-9d05-ac0c2cf8b87c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d